Lv11
30 积分 2023-02-16 加入
Mutational landscape and tyrosine kinase inhibitor sensitivity in EGFR L833 and H835 mutated non-small cell lung cancer
2天前
已完结
Mutational landscapeandtyrosinekinaseinhibitor sensitivityinEGFRL833andH835mutatednon–smallcell lungcancer
2天前
已关闭
Mutational landscape and tyrosine kinase inhibitor sensitivity in EGFR L833 and H835 mutated non–small cell lung cancer
2天前
已完结
PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations
7天前
已完结
血小板衍生生长因子受体（PDGFR）抑制剂的研究进展
8天前
已完结
Refining risk stratification in meningiomas: beyond TERT promoter mutations
11天前
已完结
A sophisticated approach to targeting TERT activity in DLBCL
13天前
已关闭
Comments on the Study of Outcomes After Radiation for Oligoprogressive Disease Sites in Patients With EGFR -Mutant Lung Cancer
13天前
已关闭
Availability of benign missense variant “truthsets” for validation of functional assays: Current status and a systematic approach
13天前
已完结
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer
22天前
已关闭
皖公网安备34019202002308
